The new mutant plant BA.2.75 is rapidly spreading in India. The number of infections is exponentially increased. The infection ability is stronger than BA.4/5?

As the Omikon variants BA.4 and BA.5 set off a new wave of epidemic in many countries, Omikon's new subtype "BA.2.75" is rapidly spreading. BA.2.75 was first discovered in India in early May of this year, and it came from BA.2, the mutant plant of Omikonia.

On July 11, according to the overseas network quoted the Associated Press, there were many cases of BA.2.75 infection in India. Experts expressed concern about the rapid spread of this strain in India. According to foreign media reports, as of July 8, BA.2.75 accounted for almost half of the new cases of infection in India.

The Indian Science and Industry Research Council scientist Metpi Tukl said that the rapid spread of this new mutant strain in India has spread faster than the local existing strains.

Matthew Binnick, director of clinical virus in the United States Meo Clinic, said: "At present, the number of strains in India has shown an exponential growth." But he also believes that the current conclusion is still time to conclude Prematurely, whether the BA.2.75 can replace BA.5 in the future is still to be determined.

Nevertheless, BA.2.75 has quietly spread in many parts of the world. In addition to India, at least 10 countries/regions including Australia, Germany, Britain, Canada and the United States have also found BA.2.75 infection cases. "This is an early signs that it is spreading," said the infectious disease of Helix, a virus sequencing company.

It is worth noting that a large number of mutations in this new variant have caused scientists to be vigilant. Medical Director of the medical institution Allan Sagullo revealed in an interview with the media that there were about 40 mutations in the mutant plant. "I don't know our immunity -natural immunity or the immunity provided by vaccines -whether it can really fight it," he said, "We are monitoring the situation in India and other countries."

Matthew Binnick said that some of the mutations in BA.2.75 are located in areas related to spyromone, which can make the virus more effectively combine to the cells.

Venate Scaria, chief scientist of the Institute of Genology and Institute of Institute of Science and Industry Research Committee of the Indian Science and Industry Research Committee, pointed out that there are nine unique mutations on BA.2.75's spiny protein. Among them, a mutation called "G446S" is related to the binding of human cell receptors, which is mainly manifested in immune escape.

Nevertheless, scientists said that vaccine and enhanced needles are still the best way to resist bearing illness. At present, it may take weeks to understand whether BA.2.75 will affect the popular trajectory.

Virus expert of the Virus of Walol Christian Medical School in India emphasized that he must continue to track and monitor the virus. "People want to return to life before the popular, but still need to be careful."

Daily Economic News

- END -